Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pseudomonas aeruginosa and pseudomonas aeruginosa-containing marine mammal vaccine

A technology of Pseudomonas aeruginosa and mammals, applied in the field of vaccines, to achieve the effect of effective homologous attack protection and strong immunity

Active Publication Date: 2018-07-06
BEIJING VBIOSCI INC +1
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The present invention aims at the technical problem of lacking an effective bacterial pneumonia vaccine for disease protection in marine mammals at present, and provides a marine mammal vaccine obtained by inactivating Pseudomonas aeruginosa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pseudomonas aeruginosa and pseudomonas aeruginosa-containing marine mammal vaccine
  • Pseudomonas aeruginosa and pseudomonas aeruginosa-containing marine mammal vaccine
  • Pseudomonas aeruginosa and pseudomonas aeruginosa-containing marine mammal vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1, acquisition and preservation of bacterial strains

[0033] 1. From a large aquarium, the stomata of marine mammals were aseptically collected in sterile plastic vials, and streaked and inoculated on hexadecanetrimethylammonium bromide agar medium (NAC). Take round, smooth, moist, and flat colonies for Gram staining and microscopic examination, select Gram-negative small bacilli for streaking and pure culture, and conduct identification according to the biochemical identification test requirements for Pseudomonas aeruginosa, and further purify and cultivate The strains were grown in pyocyanin medium, oxidase test, mannitol, nitrate reduction test, gelatin liquefaction test, 42°C growth test, etc. The results are shown in Table 1. The strain was named Pseudomonas aeruginosa DCP1 strain.

[0034] Table 1 Biochemical test results of isolated strains

[0035] Biochemical test items

result

Biochemical test items

result

Pyocyanin me...

Embodiment 2

[0058] Embodiment 2, the preparation of vaccine

[0059] Thaw the frozen bacterial solution obtained in step 2 of Example 1 at room temperature, and perform the following steps on the P2 generation strain:

[0060] 1. Antigen preparation

[0061] 1. Take the frozen bacterial liquid of the P2 generation DCP1 strain, thaw at room temperature, inoculate BHI liquid medium at a volume ratio of 1% to 10%, and culture at 37°C and 150rpm / min for 5 to 18 hours with shaking. The above-mentioned activated bacterial solution was inoculated into BHI medium at a ratio of 1% to 10%, cultured at 37°C and 150 rpm / min for 5 to 18 hours with shaking, and tested according to the appendix of the current Veterinary Pharmacopoeia of the People's Republic of China. The number of viable bacteria was calculated by counting viable bacteria.

[0062] 2. Add 37-40% formaldehyde solution to the above cultured bacterial solution and make the formaldehyde concentration 0.2%-0.5% (volume ratio, 37°C, 150rpm...

Embodiment 3

[0068] Embodiment 3, the inspection of vaccine

[0069] 1. Dosage Form

[0070] Get a 1ml disposable pipette, absorb a small amount of each vaccine prepared in Example 2 and drop it on the cold water surface installed on a 90mm disposable plate, except for the first drop, it does not spread.

[0071] 2. The stability of the vaccine

[0072] Take 10ml of each vaccine prepared in Example 2 and add it to a 10ml centrifuge tube, centrifuge at 3500r / min for 15 minutes, and the water phase precipitated at the bottom of the tube is not more than 0.5ml. The vaccines prepared in Example 2 were stored at 2-8°C for 24 months, at 37°C for 1 month or at 25°C for 3 months without discoloration, delamination and demulsification.

[0073] 3. Vaccine sterility test

[0074] 1. Take the above-mentioned antigens and carry out the sterility test according to the method of "The Veterinary Pharmacopoeia of the People's Republic of China", and the result is no bacterial growth.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses pseudomonas aeruginosa and a pseudomonas aeruginosa-containing marine mammal vaccine. A used strain is a pseudomonas aeruginosa DCP1 strain separated from a marine mammal, andhas a preservation number of CGMCC NO. 15418. The invention further discloses the marine mammal vaccine. An inactivated pseudomonas aeruginosa antigen of the marine mammal is used as an active component of the marine mammal vaccine. The invention further discloses a preparation method of the marine mammal vaccine. The preparation method comprises processes of separation of the strain, authentication, purification, antigen preparation, vaccine preparation and the like. The pseudomonas aeruginosa inactivated vaccine prepared through the preparation method disclosed by the invention is safe and reliable, can obviously increase the antibody level and has a wide application prospect.

Description

technical field [0001] The invention relates to the technical field of vaccines, in particular to a marine mammal vaccine prepared by inactivating Pseudomonas aeruginosa and the bacteria. Background technique [0002] With the improvement of people's living standards, the transformation of material needs to spiritual needs has promoted the rapid development of the domestic aquarium industry, and the demand for marine mammal resources has increased, especially for marine mammals with talent for performance. Such as bottlenose dolphins, beluga whales, etc., the number of breeding in various domestic aquariums continues to rise. When marine mammals are transferred from the vast wild ocean environment to the artificial breeding environment, the living space is greatly reduced, the food, water quality, ocean current, water temperature and other factors are limited, the living environment is strictly limited, and the artificial breeding conditions are very different from the natur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N1/20A61K39/104A61P31/04A61P11/00C12R1/385
CPCA61K39/104C12N1/20C12N1/205C12R2001/385
Inventor 张凌云郑杰马宁宁孙艳明张萌候野李燕李磊相伟
Owner BEIJING VBIOSCI INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com